ECSP034579A - Combinacion de formulaciones adyuvantes - Google Patents

Combinacion de formulaciones adyuvantes

Info

Publication number
ECSP034579A
ECSP034579A ECSP034579A ECSP034579A EC SP034579 A ECSP034579 A EC SP034579A EC SP034579 A ECSP034579 A EC SP034579A EC SP034579 A ECSP034579 A EC SP034579A
Authority
EC
Ecuador
Prior art keywords
combination
formulations
adjustment
glucosaline
granulite
Prior art date
Application number
Other languages
English (en)
Inventor
Michael Hagen
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP034579A publication Critical patent/ECSP034579A/es

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Este invento se refiere al uso de un compuesto de aminoalquilo glucosalina fosfato o un derivado o análogo del mismo, en combinación con una linfoquina, en particular un factor estimulante de la colonia de granulcito macrófago o interleuquin-12, como formulación adyuvante en una composición antígenico o inmunogénico para mejorar la respuesta inmunológico de un huésped vertebrado a un antígeno seleccionado.
ECSP034579 2000-11-10 2003-05-08 Combinacion de formulaciones adyuvantes ECSP034579A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24710000P 2000-11-10 2000-11-10

Publications (1)

Publication Number Publication Date
ECSP034579A true ECSP034579A (es) 2003-08-29

Family

ID=34115118

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP034579 ECSP034579A (es) 2000-11-10 2003-05-08 Combinacion de formulaciones adyuvantes

Country Status (5)

Country Link
AR (1) AR031211A1 (es)
EC (1) ECSP034579A (es)
MY (1) MY142635A (es)
SA (1) SA02230071B1 (es)
ZA (1) ZA200304479B (es)

Also Published As

Publication number Publication date
AR031211A1 (es) 2003-09-10
SA02230071B1 (ar) 2008-11-17
ZA200304479B (en) 2004-09-09
MY142635A (en) 2010-12-15

Similar Documents

Publication Publication Date Title
PT2364724E (pt) Composição de vacina compreendendo um adjuvante de saponina
DK1187629T3 (da) Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
NZ506603A (en) Adjuvant compositions comprising polyoxyethylene ether or polyoxyethylene ester
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
FR2781159B1 (fr) Vaccin circovirus et parvovirus porcin
CY1112698T1 (el) Ανοσογονος συνθεση
PT777490E (pt) Enterotoxina mutante eficaz como adjuvante oral nao toxico
EP2275124A3 (en) Protein-based streptococcus pneumoniae vaccines
DK1259259T3 (da) Mucosal adjuvansformulering
GB2386072A (en) Novel vaccine
IL146382A0 (en) Adjuvant combination formulations
ECSP034579A (es) Combinacion de formulaciones adyuvantes
HK1138516A1 (en) Parenteral vaccine formulations and uses thereof
WO2002038177A3 (en) Adjuvant combination formulations
UY27016A1 (es) Formulaciones de combinación de adyuvantes
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
DK1401492T3 (da) LTB4 som vaccineadjuvans